Maxim Group Starts MediciNova (MNOV) at Buy
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
Maxim Group analyst Jason McCarthy initiates coverage on MediciNova (NASDAQ: MNOV) with a Buy rating and a price target of $15.00.
Shares of MediciNova closed at $11.62 yesterday.
You May Also Be Interested In
- UPDATE: Loop Capital Starts Coinbase Global Inc. (COIN) at Buy, 'Lots of Runway Before Takeoff'
- Lake Street Capital Markets Starts S&W Seed (SANW) at Buy
- Goldman Sachs Reinstates Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) at Neutral